1. Home
  2. INTJ vs RLMD Comparison

INTJ vs RLMD Comparison

Compare INTJ & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTJ
  • RLMD
  • Stock Information
  • Founded
  • INTJ 2016
  • RLMD 2004
  • Country
  • INTJ Hong Kong
  • RLMD United States
  • Employees
  • INTJ N/A
  • RLMD N/A
  • Industry
  • INTJ
  • RLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTJ
  • RLMD Health Care
  • Exchange
  • INTJ NYSE
  • RLMD Nasdaq
  • Market Cap
  • INTJ 12.7M
  • RLMD 11.5M
  • IPO Year
  • INTJ 2024
  • RLMD N/A
  • Fundamental
  • Price
  • INTJ $0.95
  • RLMD $0.30
  • Analyst Decision
  • INTJ
  • RLMD Hold
  • Analyst Count
  • INTJ 0
  • RLMD 4
  • Target Price
  • INTJ N/A
  • RLMD $4.25
  • AVG Volume (30 Days)
  • INTJ 80.0K
  • RLMD 2.1M
  • Earning Date
  • INTJ 11-01-2024
  • RLMD 03-18-2025
  • Dividend Yield
  • INTJ N/A
  • RLMD N/A
  • EPS Growth
  • INTJ 30.19
  • RLMD N/A
  • EPS
  • INTJ 0.07
  • RLMD N/A
  • Revenue
  • INTJ $2,341,977.00
  • RLMD N/A
  • Revenue This Year
  • INTJ N/A
  • RLMD N/A
  • Revenue Next Year
  • INTJ N/A
  • RLMD N/A
  • P/E Ratio
  • INTJ $13.66
  • RLMD N/A
  • Revenue Growth
  • INTJ 25.78
  • RLMD N/A
  • 52 Week Low
  • INTJ $0.72
  • RLMD $0.28
  • 52 Week High
  • INTJ $7.87
  • RLMD $7.22
  • Technical
  • Relative Strength Index (RSI)
  • INTJ N/A
  • RLMD 30.81
  • Support Level
  • INTJ N/A
  • RLMD $0.28
  • Resistance Level
  • INTJ N/A
  • RLMD $0.36
  • Average True Range (ATR)
  • INTJ 0.00
  • RLMD 0.04
  • MACD
  • INTJ 0.00
  • RLMD 0.02
  • Stochastic Oscillator
  • INTJ 0.00
  • RLMD 7.21

About INTJ INTELLIGENT GROUP LTD

Intelligent Group Ltd is a professional services provider in Hong Kong that principally engages in the provision of Financial PR services. The company provides a substantial number of holistic and comprehensive Financial PR services to its clients through IJL, its key operating entity in Hong Kong. It advises its clients on their communications and reputation management efforts. Its Financial PR services include creating multi-stakeholder communications programs, arranging press conferences and interviews, participating in the preparation of news releases and shareholders' meetings, monitoring news publications, identifying shareholders, targeting potential investors, organizing corporate events, and implementing crisis management policies and procedures.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: